Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Loxoprofen Sodium Patch
Patch · 20mg/40mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB814)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pentoxifylline tablet
tablet · 0.4g
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB813)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Iron Proteinsuccinylate Oral Solution
Oral Solution · 15ml:40mg
- Therapy
- Others > Hematology
- Status
- Official FDF licensing catalog (UB812)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Urapidil Tablet
Tablet
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB811)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ligustrazine Phosphate Injection
Injection · 5ml:0.1g
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB810)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pentoxifylline Injection
Injection · 5ml:0.1g
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB809)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Urapidil Hydrochloride Injection
Injection · 5ml:25mg / 10ml:50ml
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB808)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Granisetron Hydrochloride Injection
Injection · 3ml:3mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB807)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ornithine Aspartate Injection
Injection · 10ml:5g
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB806)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pantoprazole Sodium for Injection
for Injection · 40mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB805)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Esomeprazole Sodium for Injection
for Injection · 40mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB804)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tetracaine HCL for Injection
for Injection · 10mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB803)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lidocaine Hydrochloride Injection
Injection · 5ml:0.1g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB802)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ropivacaine Hydrochloride Injection
Injection · 10ml:75mg / 10ml:100mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB801)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Enflurane for Inhalation
for Inhalation · 150ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB800)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Desflurane for Inhalation
for Inhalation · 240ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB799)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sevoflurane for Inhalation
for Inhalation · 250ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB798)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Isoflurane for Inhalation
for Inhalation · 100ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB797)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Progesterone (Hard) Capsules
Capsules
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB796)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Progesterone Suppositories
Suppositories
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB795)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dienogest Tablets
Tablets
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB794)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Prednisolone Tablets
Tablets · 5mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB793)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Finasteride Tablets
Tablets · 5mg
- Therapy
- Nephrology & Urology
- Status
- Official FDF licensing catalog (UB792)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dydrogesterone Tablets
Tablets
- Therapy
- Others > Women's Health
- Status
- Official FDF licensing catalog (UB791)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Estradiol Valerate Tablets
Tablets
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB790)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Estradiol Tablets
Tablets
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB789)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Medroxyprogesterone Acetate Tablets
Tablets
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB788)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lidocaine Injection
Injection · 1%; 2%; 4%
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB781)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Irbesartan Tablet
Tablet · 75mg; 150mg; 300mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB780)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Acyclovir Capsule
Capsule · 200mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB779)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Binaprofen Injection
Injection · 4ml: 94.25mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB777)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dimdazenil Capsules
Capsules · 2.5 mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB776)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Human Interleukin-11 for Injection
for Injection · 3mg and 5mg/vial
- Therapy
- Others > Hematology
- Status
- Official FDF licensing catalog (UB775)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Human Granulocyte Colony-Stimulating Factor Injection
Injection · 150mcg and 300mcg/vial; 300mcg/0.5ml/PFS
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB774)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Human Granulocyte/Macrophage Colony-stimulating Factor for Injection
for Injection · 100mcg, 150mcg and 300mcg/vial
- Therapy
- Others > Hematology
- Status
- Official FDF licensing catalog (UB773)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Telpegfilgrastim Injection
Injection · 2mg/ml/PFS
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB772)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Inpegsomatropin Injection
Injection · 2.5mg/0.35mL/PFS; 3.0mg/0.35mL/PFS; 3.5mg/0.35mL/PFS; 5.0mg/0.35mL/PFS;
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB771)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Peginterferon alfa-2b Injection
Injection · 180mcg(0.66MU)/0.5ml/PFS
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB770)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Loxoprofen Sodium Cataplasms
Cataplasms · 10g:100mg(14cm*10cm)
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB768)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules
Capsules · 50mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB767)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China, South Korea
Formulation (FDF)
Penpulimab Injection
Injection · 100mg（10ml）/bottle
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB766)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lenvatinib Mesilate Capsules
Capsules · 4mg; 10mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB765)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Trifluridine and Tipiracil Hydrochloride Tablets
Tablets
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB764)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Bevacizumab Injection
Injection · 100mg（4ml）/bottle
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB763)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Rituximab Injection
Injection · 100mg（10ml）/bottle
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB762)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Trastuzumab Injection
Injection · 150 mg/bottle
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB761)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Efbemalenograstim alfa injection
injection · 20mg（1.0ml）/vial
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB760)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Pertuzumab Injection
Injection
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB759)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China